Current Law Journal Content
Washington & Lee Law School
  Current Law Journal Content
                  an index to legal periodicals

  Biotechnology Law Report
  Volume 27, Number 6, December 2008
  homepage                   other issues

  • Papers
  • Intellectual Property Protection of Plant Varieties in Asian Developing Countries
        Wenqi Liu, Lingyun Gu
        p.525-531                                                                              +cite        
  • The Olanzapine Patent Dispute: German Court Grants a Preliminary Injunction on a Patent Invalidated by the First-Instance Federal Patent Court
        Gerhard Barth, Franz-Josef Zimmer
        p.532-536                                                                              +cite        

  • Regulatory Affairs—Pharmaceutical
  • Australia Allows Human Embryo Cloning; One-Stop Shop for Drug Safety Information; Ranbaxy Can Ship Drugs to U.S. from All Plants; Guidance on Potency of Cell and Gene Therapeutics; Cepheid Gets Clearance for Fast MRSA Test
        p.537-539                                                                              +cite    

  • Clinical Trials
  • Negative Clinical Trial Results Less Likely to Be Published; Pfizer Said to Have Hidden Negative Trial Results
        p.540-540                                                                              +cite    

  • Regulatory Affairs—Agricultural and Environmental
  • Regulations on Genetically Engineered Animals; Publications from FDA, APHIS Released; Recombinant Rabies Vaccine to Be Tested; Herbicide-Tolerant Soybeans Deregulated; G8 Nations Want Greater Use of Genetically Engineered Plants; France May Be Fined over Laws on Genetically Engineered Crops; Concern About Nanotechnology Effects on Bacteria
        p.541-542                                                                              +cite    

  • Patents
  • Present Intellectual Property System May Be Hampering Medicine and Biological Sciences; Four Inventors Removed from Patent on Stem Cells from Adipose Tissue; CAFC Agrees Analytical Technique Patent Is Obvious; Genetic Technologies Corrects False Press Reports; BLR Archives: You Have to Pay the Fees; EPO Rejects RNAi Patent
        p.543-549                                                                              +cite    

  • Patent Litigation
  • Roche Is Not Infringing Carnegie Mellon Patents Disclosing Method of Producing Enzyme; Amgen Wins Permanent Injunction Blocking Sales of Competing Epo Formulation; Co-op Concedes It Is Violating Monsanto Patents; CAFC Agrees Claims for Declaratory Judgment of Noninfringement Should Have Been Dismissed; Patent on Treatment of ALS with Riluzole Not Anticipated; BLR Archives: Pfizer Loses One Patent for Double Patenting But Keeps Two More; §121 Protection Applies Only to Divisional Applications; Colliding Generic Companies; University of Iowa Sues Amgen for Infringement
        p.550-557                                                                              +cite    

  • Licensing and Collaborations
  • Is This License Still in Effect?; Invitrogen Accuses Vanderbilt, Oxford of License Violation
        p.558-560                                                                              +cite    

  • Financial and Shareholder Affairs
  • FASB Proposal Protested; Monsanto Sells Bovine Hormone Franchise; Parallel Drug Distributors May Lose to Counterfeit Prevention Rules
        p.561-562                                                                              +cite    

  • Misconduct
  • Falsified Data, But No Misconduct; FBI Says One Person Solely Responsible for Anthrax Attacks
        p.563-563                                                                              +cite    

  • Scientific and Medical Developments
  • Embryos Will Still Be Necessary; Do Bt Crops Protect Other Plants?; Rules Promulgated for Racial Identification; Nanotechnology Imaging Technique Tested
        p.564-565                                                                              +cite    
  • On the Move
        p.566-567                                                                              +cite    

  • Texts
  • Draft Guidance for Industry: Potency Tests for Cellular and Gene Therapy Products
        p.568-577                                                                              +cite    
  • FR Doc E8-21977: Animal and Plant Health Inspection Service: Genetically Engineered Animals
        p.578-579                                                                              +cite    
  • Findings of Fact and Conclusions of Law: University of Pittsburg of the Commonwealth System of Higher Education v. Marc H. Hedrick, Prosper Benhaim, Hermann Peter Lorenz, and Min Zhu (No. CV04-9014 CBM [AJWx])
        p.580-587                                                                              +cite    
  • In re Melvin J. Swanson and Patrick E. Guire (Reexamination No. 90/006,785)
        p.588-596                                                                              +cite    
  • Carnegie Mellon University v. Hoffmann-La Roche Inc., Roche Molecular Systems, Inc., Roche Diagnostics Corporation, Laboratory Corporation of America, and Applera Corporation (2007-1267)
        p.597-606                                                                              +cite    
  • Pfizer, Inc., Pharmacia Corp., Pharmacia & Upjohn, Inc., Pharmacia & Upjohn Company, G.D. Searle & Co., G.D. Searle LLC, Searle LLC (Delaware), and Searle LLC (Nevada) v. Teva Pharmaceuticals USA, Inc. (2007-1271)
        p.607-615                                                                              +cite    
  • Janssen Pharmaceutica, N.V. and Janssen, L.P. v. Apotex, Inc. (2008-1062)
        p.616-622                                                                              +cite    
  • Coming Events
        p.623-626                                                                              +cite